Skip to main content

Table 3 Hemodynamic data in patients with heart failure and additional sepsis treated with and without dobutamine

From: Near-infrared spectroscopy during stagnant ischemia estimates central venous oxygen saturation and mixed venous oxygen saturation discrepancy in patients with severe left heart failure and additional sepsis/septic shock

Hemodynamic data

All

(n = 52)

Treatment

with dobutemine

(n = 43)

Treatment

without dobutamine

(n = 9)

P value

HR (bpm)

113 ± 20

113 ± 20

114 ± 21

0.8

SAP (mmHg)

118 ± 21

117 ± 20

124 ± 27

0.9

DAP (mmHg)

74 ± 22

76 ± 22

66 ± 21

0.4

PAPs (mmHg)

57 ± 14

56 ± 13

57 ± 16

0.9

PAPd (mmHg)

28 ± 8

27 ± 8

29 ± 7

0.4

CVP (mmHg)

16 ± 5

16 ± 5

15 ± 5

0.8

DO2 (ml/kg/min)

406 ± 128

391 ± 134

470 ± 121

0.1

VO2 (ml/kg/min)

118 ± 42

116 ± 43

126 ± 38

0.5

PAOP (mmHg)

23 ± 7

24 ± 7

22 ± 8

0.7

CI (L/min/m2)

2.5 ± 0.7

2.4 ± 0.7

2.9 ± 0.6

0.03

SvO2 (%)

67 ± 10%

66 ± 10

71 ± 7

0.2

ScvO2 (%)

77 ± 8%

77 ± 7

78 ± 10

0.6

  1. Bold: statistically significant difference, P < 0.05.
  2. CI, cardiac index; CVP, central venous pressure; DAP, diastolic arterial pressure; DO2, delivery of oxygen; HR, heart rate; PAOP, pulmonary artery occlusion pressure; PAPd, diastolic pulmonary arterial pressure; PAPs, systolic pulmonary arterial pressure; SAP, systolic arterial pressure; SvO2, mixed venous hemoglobin saturation; ScvO2, central venous oxygen saturation; VO2, oxygen consumption.